L-ORNITHINE L-ASPARTATE-MATERIALS USED TO PRODUCE DRUGS-PTPL: 1839/06-KQ/TCHQ/PTPLMN-LOT; LOA 22068-NSX: 23/03/2022-HSD: MARCH 22 2025
L-ORNITHINE L-ASPARTATE-MATERIALS USED TO PRODUCE DRUGS-PTPL: 1839/06-KQ/TCHQ/PTPLMN-LOT; LOA 22068-NSX: 23/03/2022-HSD: MARCH 22 2025
07-August-2023
292249000000
L-ORNITHINE-L-ASPARTATE POWDER FORM NLSX MEDICINE FORTEC.KQPTPL:2275/TB-TCHQ(APRIL 18 2019).BATCH NUMBER:LOLA0209&LOLA0208(NSX:OCTOBER 13 2022-HSD:OCTOBER 12 2025)-LOLA0207&LOLA0206( NSX:06.10.2022-HSD:05.10.2025).100% BRAND NEW
L-ORNITHINE-L-ASPARTATE POWDER FORM NLSX MEDICINE FORTEC.KQPTPL:2275/TB-TCHQ(APRIL 18 2019).BATCH NUMBER:LOLA0209&LOLA0208(NSX:OCTOBER 13 2022-HSD:OCTOBER 12 2025)-LOLA0207&LOLA0206( NSX:06.10.2022-HSD:05.10.2025).100% BRAND NEW
06-November-2023
300490990000
LEVOMELS INFUSION. VN-16872-13. MEDICINE CONTAINING L-ORNITHINE-L-ASPARTATE 5G/10ML IS EFFECTIVE IN LIVER DISEASES. BOX OF 10 TUBES OF 10ML; INFUSION MEDICINE. LOT NUMBER: 23001. MANUFACTURER: SEPTEMBER 25 2023. EXPIRY DATE: SEPTEMBER 24 2026
LEVOMELS INFUSION. VN-16872-13. MEDICINE CONTAINING L-ORNITHINE-L-ASPARTATE 5G/10ML IS EFFECTIVE IN LIVER DISEASES. BOX OF 10 TUBES OF 10ML; INFUSION MEDICINE. LOT NUMBER: 23001. MANUFACTURER: SEPTEMBER 25 2023. EXPIRY DATE: SEPTEMBER 24 2026
30-March-2021
300490990000
MASLIVE INJ. VN-17135-13. THE DRUG HAS THE EFFECT OF TREATING LIVER DISEASE CONTAINING L-ORNITHINE-L-ARPARTATE 500MG/5ML. BOX OF 10 AMPOULES X 5ML SOLUTION FOR INJECTION. LOT NUMBER: MSLG(003+004). PRODUCER: FEBRUARY 18 2021. HD: FEBRUARY 17 2024.
MASLIVE INJ. VN-17135-13. THE DRUG HAS THE EFFECT OF TREATING LIVER DISEASE CONTAINING L-ORNITHINE-L-ARPARTATE 500MG/5ML. BOX OF 10 AMPOULES X 5ML SOLUTION FOR INJECTION. LOT NUMBER: MSLG(003+004). PRODUCER: FEBRUARY 18 2021. HD: FEBRUARY 17 2024.